3 Citations (Scopus)

Abstract

The src-related tyrosine kinase p56(lck) is overexpressed in the mouse leukemia cell line LSTRA. Although p56(lck) is thought to be a specific T- cell marker, we found that LSTRA cells can be induced to differentiate towards macrophages or granulocytes by the tumor promoter 12-O- tetradecanoylphorbol-13-acetate or the cyclic nucleotide analogue, dibutyryl cAMP, respectively. Treatment of LSTRA cells with 12-O-tetradecanoylphorbol- 13-acetate resulted in marked alterations in morphology including increased size, adherence, and spreading on culture dishes. These cells also ceased proliferating, accumulated in G0-G1 and expressed nonspecific esterase activity. In contrast, although LSTRA cells treated with dibutyryl cAMP stopped growing and accumulated in G0-G1, these cells expressed functionally active chemotactic peptide receptors and became irregular and granular in appearance. Differentiation of LSTRA cells was also found to be associated with altered expression of p56(lck). Thus, while 12-O- tetradecanoylphorbol-13-acetate treatment caused the cells to produce higher molecular weight forms of p56(lck), dibutyryl cAMP treatment resulted in increased expression of total p56(lck) mRNA as well as the more mature type II p56(lck) mRNA transcript. There were no major alterations in p56(lck) kinase activity in vitro following differentiation. Phospholipase Cγ and p21(ras)GAP, two putative substrates for the tyrosine kinase activity of p56(lck), were found to be constitutively phosphorylated on tyrosine in LSTRA cells. Tyrosine phosphorylation of these substrates was not altered following differentiation. These results indicate that LSTRA cells are relatively early precursors that have the capacity to develop along the myeloid differentiation pathway. Furthermore, expression of p56(lck) does not appear to predispose LSTRA cells to mature along a particular developmental pathway.

Original languageEnglish (US)
Pages (from-to)1215-1223
Number of pages9
JournalCell Growth and Differentiation
Volume5
Issue number11
StatePublished - Jan 1 1994

Fingerprint

Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
Cell Differentiation
Tetradecanoylphorbol Acetate
Tyrosine
ras GTPase-Activating Proteins
Formyl Peptide Receptor
Proto-Oncogene Proteins p21(ras)
Carboxylesterase
Messenger RNA
src-Family Kinases
Cyclic Nucleotides
Type C Phospholipases
Granulocytes
Carcinogens
Protein-Tyrosine Kinases
Leukemia
Molecular Weight
Macrophages

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cell Biology

Cite this

@article{05daa0ba1fd748d5b6f63693bb55819e,
title = "Alterations in expression of p56(lck) during myeloid differentiation of LSTRA cells",
abstract = "The src-related tyrosine kinase p56(lck) is overexpressed in the mouse leukemia cell line LSTRA. Although p56(lck) is thought to be a specific T- cell marker, we found that LSTRA cells can be induced to differentiate towards macrophages or granulocytes by the tumor promoter 12-O- tetradecanoylphorbol-13-acetate or the cyclic nucleotide analogue, dibutyryl cAMP, respectively. Treatment of LSTRA cells with 12-O-tetradecanoylphorbol- 13-acetate resulted in marked alterations in morphology including increased size, adherence, and spreading on culture dishes. These cells also ceased proliferating, accumulated in G0-G1 and expressed nonspecific esterase activity. In contrast, although LSTRA cells treated with dibutyryl cAMP stopped growing and accumulated in G0-G1, these cells expressed functionally active chemotactic peptide receptors and became irregular and granular in appearance. Differentiation of LSTRA cells was also found to be associated with altered expression of p56(lck). Thus, while 12-O- tetradecanoylphorbol-13-acetate treatment caused the cells to produce higher molecular weight forms of p56(lck), dibutyryl cAMP treatment resulted in increased expression of total p56(lck) mRNA as well as the more mature type II p56(lck) mRNA transcript. There were no major alterations in p56(lck) kinase activity in vitro following differentiation. Phospholipase Cγ and p21(ras)GAP, two putative substrates for the tyrosine kinase activity of p56(lck), were found to be constitutively phosphorylated on tyrosine in LSTRA cells. Tyrosine phosphorylation of these substrates was not altered following differentiation. These results indicate that LSTRA cells are relatively early precursors that have the capacity to develop along the myeloid differentiation pathway. Furthermore, expression of p56(lck) does not appear to predispose LSTRA cells to mature along a particular developmental pathway.",
author = "A. Garcia-Welsh and Debra Laskin and Christopher Molloy and Jeffrey Laskin",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "5",
pages = "1215--1223",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

Alterations in expression of p56(lck) during myeloid differentiation of LSTRA cells. / Garcia-Welsh, A.; Laskin, Debra; Molloy, Christopher; Laskin, Jeffrey.

In: Cell Growth and Differentiation, Vol. 5, No. 11, 01.01.1994, p. 1215-1223.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Alterations in expression of p56(lck) during myeloid differentiation of LSTRA cells

AU - Garcia-Welsh, A.

AU - Laskin, Debra

AU - Molloy, Christopher

AU - Laskin, Jeffrey

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The src-related tyrosine kinase p56(lck) is overexpressed in the mouse leukemia cell line LSTRA. Although p56(lck) is thought to be a specific T- cell marker, we found that LSTRA cells can be induced to differentiate towards macrophages or granulocytes by the tumor promoter 12-O- tetradecanoylphorbol-13-acetate or the cyclic nucleotide analogue, dibutyryl cAMP, respectively. Treatment of LSTRA cells with 12-O-tetradecanoylphorbol- 13-acetate resulted in marked alterations in morphology including increased size, adherence, and spreading on culture dishes. These cells also ceased proliferating, accumulated in G0-G1 and expressed nonspecific esterase activity. In contrast, although LSTRA cells treated with dibutyryl cAMP stopped growing and accumulated in G0-G1, these cells expressed functionally active chemotactic peptide receptors and became irregular and granular in appearance. Differentiation of LSTRA cells was also found to be associated with altered expression of p56(lck). Thus, while 12-O- tetradecanoylphorbol-13-acetate treatment caused the cells to produce higher molecular weight forms of p56(lck), dibutyryl cAMP treatment resulted in increased expression of total p56(lck) mRNA as well as the more mature type II p56(lck) mRNA transcript. There were no major alterations in p56(lck) kinase activity in vitro following differentiation. Phospholipase Cγ and p21(ras)GAP, two putative substrates for the tyrosine kinase activity of p56(lck), were found to be constitutively phosphorylated on tyrosine in LSTRA cells. Tyrosine phosphorylation of these substrates was not altered following differentiation. These results indicate that LSTRA cells are relatively early precursors that have the capacity to develop along the myeloid differentiation pathway. Furthermore, expression of p56(lck) does not appear to predispose LSTRA cells to mature along a particular developmental pathway.

AB - The src-related tyrosine kinase p56(lck) is overexpressed in the mouse leukemia cell line LSTRA. Although p56(lck) is thought to be a specific T- cell marker, we found that LSTRA cells can be induced to differentiate towards macrophages or granulocytes by the tumor promoter 12-O- tetradecanoylphorbol-13-acetate or the cyclic nucleotide analogue, dibutyryl cAMP, respectively. Treatment of LSTRA cells with 12-O-tetradecanoylphorbol- 13-acetate resulted in marked alterations in morphology including increased size, adherence, and spreading on culture dishes. These cells also ceased proliferating, accumulated in G0-G1 and expressed nonspecific esterase activity. In contrast, although LSTRA cells treated with dibutyryl cAMP stopped growing and accumulated in G0-G1, these cells expressed functionally active chemotactic peptide receptors and became irregular and granular in appearance. Differentiation of LSTRA cells was also found to be associated with altered expression of p56(lck). Thus, while 12-O- tetradecanoylphorbol-13-acetate treatment caused the cells to produce higher molecular weight forms of p56(lck), dibutyryl cAMP treatment resulted in increased expression of total p56(lck) mRNA as well as the more mature type II p56(lck) mRNA transcript. There were no major alterations in p56(lck) kinase activity in vitro following differentiation. Phospholipase Cγ and p21(ras)GAP, two putative substrates for the tyrosine kinase activity of p56(lck), were found to be constitutively phosphorylated on tyrosine in LSTRA cells. Tyrosine phosphorylation of these substrates was not altered following differentiation. These results indicate that LSTRA cells are relatively early precursors that have the capacity to develop along the myeloid differentiation pathway. Furthermore, expression of p56(lck) does not appear to predispose LSTRA cells to mature along a particular developmental pathway.

UR - http://www.scopus.com/inward/record.url?scp=0028172793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028172793&partnerID=8YFLogxK

M3 - Article

C2 - 7531490

AN - SCOPUS:0028172793

VL - 5

SP - 1215

EP - 1223

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 11

ER -